Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Resveratrol, obesity and diabetes.

Szkudelska K, Szkudelski T.

Eur J Pharmacol. 2010 Jun 10;635(1-3):1-8. doi: 10.1016/j.ejphar.2010.02.054. Epub 2010 Mar 19. Review.

PMID:
20303945
2.

Anti-diabetic effects of resveratrol.

Szkudelski T, Szkudelska K.

Ann N Y Acad Sci. 2011 Jan;1215:34-9. doi: 10.1111/j.1749-6632.2010.05844.x. Review.

PMID:
21261639
3.

Resveratrol and diabetes: from animal to human studies.

Szkudelski T, Szkudelska K.

Biochim Biophys Acta. 2015 Jun;1852(6):1145-54. doi: 10.1016/j.bbadis.2014.10.013. Epub 2014 Oct 27. Review.

4.

An adipocentric perspective of resveratrol as a calorie restriction mimetic.

Barger JL.

Ann N Y Acad Sci. 2013 Jul;1290:122-9. doi: 10.1111/nyas.12212. Review.

PMID:
23855474
5.

Resveratrol and health--a comprehensive review of human clinical trials.

Smoliga JM, Baur JA, Hausenblas HA.

Mol Nutr Food Res. 2011 Aug;55(8):1129-41. doi: 10.1002/mnfr.201100143. Epub 2011 Jun 20. Review.

PMID:
21688389
6.

The insulin-suppressive effect of resveratrol - an in vitro and in vivo phenomenon.

Szkudelski T.

Life Sci. 2008 Feb 13;82(7-8):430-5. doi: 10.1016/j.lfs.2007.12.008. Epub 2007 Dec 23.

PMID:
18206958
7.

Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.

Leontieva OV, Paszkiewicz G, Demidenko ZN, Blagosklonny MV.

Cell Death Dis. 2013 Jan 24;4:e472. doi: 10.1038/cddis.2012.202.

8.

Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.

Louis XL, Thandapilly SJ, MohanKumar SK, Yu L, Taylor CG, Zahradka P, Netticadan T.

J Nutr Biochem. 2012 Sep;23(9):1163-9. doi: 10.1016/j.jnutbio.2011.06.010. Epub 2011 Dec 1.

PMID:
22137269
9.

Novel strategies for preventing diabetes and obesity complications with natural polyphenols.

Carpene C, Gomez-Zorita S, Deleruyelle S, Carpene MA.

Curr Med Chem. 2015;22(1):150-64. Review.

PMID:
25139462
11.

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

Timmers S, Hesselink MK, Schrauwen P.

Ann N Y Acad Sci. 2013 Jul;1290:83-9. doi: 10.1111/nyas.12185. Review.

PMID:
23855469
12.

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.

Rivera L, Morón R, Zarzuelo A, Galisteo M.

Biochem Pharmacol. 2009 Mar 15;77(6):1053-63. doi: 10.1016/j.bcp.2008.11.027. Epub 2008 Dec 3.

PMID:
19100718
13.

Resveratrol and diabetes.

Vallianou NG, Evangelopoulos A, Kazazis C.

Rev Diabet Stud. 2013 Winter;10(4):236-42. doi: 10.1900/RDS.2013.10.236. Epub 2014 Feb 10. Review.

14.

The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity.

Arias N, Macarulla MT, Aguirre L, Martínez-Castaño MG, Gómez-Zorita S, Miranda J, Martínez JA, Portillo MP.

J Physiol Biochem. 2011 Sep;67(3):471-7. doi: 10.1007/s13105-011-0086-2. Epub 2011 Apr 1.

PMID:
21455758
15.

Resveratrol inhibits insulin secretion from rat pancreatic islets.

Szkudelski T.

Eur J Pharmacol. 2006 Dec 15;552(1-3):176-81. Epub 2006 Sep 27.

PMID:
17069794
16.

Diabetic complications in pregnancy: is resveratrol a solution?

Singh CK, Kumar A, Lavoie HA, Dipette DJ, Singh US.

Exp Biol Med (Maywood). 2013 May;238(5):482-90. doi: 10.1177/1535370212473704. Epub 2013 May 29. Review.

17.

Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.

Carrizzo A, Forte M, Damato A, Trimarco V, Salzano F, Bartolo M, Maciag A, Puca AA, Vecchione C.

Food Chem Toxicol. 2013 Nov;61:215-26. doi: 10.1016/j.fct.2013.07.021. Epub 2013 Jul 18. Review.

PMID:
23872128
18.

The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects.

Kim MH, Yoo DS, Lee SY, Byeon SE, Lee YG, Min T, Rho HS, Rhee MH, Lee J, Cho JY.

Pharmazie. 2011 Apr;66(4):293-300.

PMID:
21612158
19.

Chronic resveratrol administration has beneficial effects in experimental model of type 2 diabetic rats.

Soufi FG, Sheervalilou R, Vardiani M, Khalili M, Alipour MR.

Endocr Regul. 2012 Apr;46(2):83-90.

PMID:
22540856
20.

Beneficial role of dietary phytoestrogens in obesity and diabetes.

Bhathena SJ, Velasquez MT.

Am J Clin Nutr. 2002 Dec;76(6):1191-201. Review.

Items per page

Supplemental Content

Write to the Help Desk